JOVNU Trademark

Trademark Overview

On Monday, February 1, 2016, a trademark application was filed for JOVNU with the United States Patent and Trademark Office. The USPTO has given the JOVNU trademark a serial number of 86892637. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 20, 2025. This trademark is owned by Glaxo Group Limited. The JOVNU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
jovnu

General Information

Serial Number86892637
Word MarkJOVNU
Filing DateMonday, February 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 20, 2025
Registration Number5619884
Registration DateTuesday, December 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Wednesday, May 18, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 8, 2017SOU TEAS EXTENSION RECEIVED
Friday, February 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 4, 2016NEW APPLICATION ENTERED
Thursday, February 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 17, 2016ASSIGNED TO EXAMINER
Wednesday, February 8, 2017SOU EXTENSION 1 FILED
Wednesday, February 8, 2017SOU EXTENSION 1 GRANTED
Thursday, July 13, 2017SOU TEAS EXTENSION RECEIVED
Thursday, July 13, 2017SOU EXTENSION 2 FILED
Thursday, July 13, 2017SOU EXTENSION 2 GRANTED
Saturday, July 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2018SOU EXTENSION 3 FILED
Tuesday, February 13, 2018SOU EXTENSION 3 GRANTED
Thursday, February 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 12, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, July 25, 2018ASSIGNED TO PETITION STAFF
Thursday, July 26, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, July 26, 2018ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Wednesday, August 8, 2018NOTICE OF ALLOWANCE CANCELLED
Wednesday, August 29, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 18, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 20, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

jovnu pharmaceutical treatment disorders preparations substances diseases hepatological ophthalmic oncological dysfunction